353 results
Page 15 of 18
8-K
EX-99.1
v33kj6jvc
17 Nov 10
Additional Phase 3 Clinical Trial Data Published in Annals of Neurology Showing Dalfampridine
12:00am
8-K
po7xptzuga
1 Nov 10
Results of Operations and Financial Condition
12:00am
8-K
euoc4dwoe
19 Oct 10
Other Events
12:00am
8-K
di9f1txlq3y l2
15 Oct 10
Other Events
12:00am
8-K
EX-99
cw86odf4
3 Aug 10
Results of Operations and Financial Condition
12:00am
8-K
EX-99
hw4sm
20 Jul 10
Acorda Therapeutics Announces Receipt of NIH Grant for Development of GGF2 in Heart Failure
12:00am
8-K
enftb11l7p1h
7 Jul 10
Acorda Therapeutics Announces Douglas Kargman Joins as Vice President of Drug Safety
12:00am
8-K
EX-99
ud6 wa4ivaogz
7 Jul 10
Acorda Therapeutics Announces Douglas Kargman Joins as Vice President of Drug Safety
12:00am
8-K
EX-99.1
vkd9l
30 Apr 10
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
z5h59bx
20 Apr 10
Acorda Therapeutics Announces Investigational New Drug Application Accepted for GGF2 for Treatment of Heart Failure
12:00am
8-K
EX-99.1
c48 57onwkqlou
13 Apr 10
Acorda Therapeutics Announces Data on AMPYRA™ (dalfampridine) Presented at American Academy of Neurology Meeting
12:00am
8-K
EX-99.1
y9y462y8og6
22 Mar 10
Other Events
12:00am
8-K
EX-99.1
qg2lvm ecdiw
1 Mar 10
Other Events
12:00am
8-K
EX-99.1
9ps4vh9fajcq3ubrx98
23 Feb 10
Acorda Therapeutics Reports Fourth Quarter and Full Year 2009 Financial Results
12:00am
8-K
EX-99.1
la8ww
22 Feb 10
Acorda Therapeutics Announces Adrian L. Rabinowicz Joins as Senior Vice President of Medical Affairs
12:00am
8-K
EX-99.1
muvw8
3 Feb 10
Other Events
12:00am